Literature DB >> 16189377

Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysis.

Joakim Dillner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16189377     DOI： 10.1373/clinchem.2005.055483

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

1.  Antibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.

Authors:  Parinda A Mehta; Sharon Sauter; Xue Zhang; Stella M Davies; Suzanne I Wells; Kasiani C Myers; Gitika Panicker; Elizabeth R Unger; Melinda Butsch Kovacic
Journal:  Vaccine       Date:  2017-10-16       Impact factor: 3.641

Review 2.  Why current quantitative serology is not quantitative and how systems immunology could provide solutions.

Authors:  József Prechl
Journal:  Biol Futur       Date:  2021-02-20

3.  Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigens.

Authors:  Colomba Giorgi; Paola Di Bonito; Felicia Grasso; Stefania Mochi; Luisa Accardi; Maria Gabriella Donà; Margherita Branca; Silvano Costa; Luciano Mariani; Alberto Agarossi; Marco Ciotti; Kari Syrjänen
Journal:  Infect Agent Cancer       Date:  2008-06-26       Impact factor: 2.965

4.  Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers.

Authors:  Jyoti Malhotra; Tim Waterboer; Michael Pawlita; Angelika Michel; Qiuyin Cai; Wei Zheng; Yu-Tang Gao; Qing Lan; Nathaniel Rothman; Hilde Langseth; Tom K Grimsrud; Jian-Min Yuan; Woon-Puay Koh; Renwei Wang; Alan A Arslan; Anne Zeleniuch-Jacquotte; Paolo Boffetta
Journal:  Br J Cancer       Date:  2016-09-15       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.